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Summary 
Introduction: 
Surveillance of surgical site infections (SSI) is a core component of effective infection control 
practices, though its impact has not been quantified on a large scale. This study aims to determine the 
time-trend of SSI rates in surveillance networks. 
 
Methods: 
SSI surveillance networks provided procedure-specific data on numbers of SSIs and operations, 
stratified by hospitals’ year of participation in the surveillance, to capture length of participation as an 
exposure. Pooled and procedure-specific random-effects Poisson regression was performed to obtain 
yearly rate ratios (RR) with 95% confidence intervals (CI), and including surveillance network as 
random intercept.  
 
Results: 
Of 36 invited networks, 17 networks from 15 high-income countries across Europe, Asia and 
Australasia participated in the study. Aggregated data on 17 surgical procedures (cardio-vascular, 
digestive, gynaecologic-obstetrical, neurosurgical, and orthopaedic) were collected, resulting in data 
concerning 5,831,737 operations and 113,166 SSIs. There was a significant decrease in overall SSI 
rates over surveillance time resulting in a 35% reduction at the ninth (final) included year of 
surveillance (RR 0.65; 95% CI 0.63-0.67). There were large variations across procedure-specific 
trends, but strong consistent decreases were observed for colorectal surgery, herniorrhaphy, Caesarean 
section, hip prosthesis, and knee prosthesis. 
 
Conclusion: 
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In this large, international cohort study, pooled SSI rates showed a were associated with a stable and 
sustainable decrease after joining a SSI surveillance network; a causal relationship is possible, 
although unproven. There was heterogeneity in procedure-specific trends. These findings support the 
pivotal role of surveillance in reducing infection rates and call for widespread implementation of 
hospital-based SSI surveillance in high-income countries.  
 
Summary word count: 256 
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Introduction 
Surgical site infections (SSIs) are a leading cause of healthcare-associated infections (HAI) [1, 2]. 
They negatively impact both on patients and healthcare systems, as they are associated with poorer 
clinical outcomes, and increased length of hospital stay, readmissions and/or reoperations, antibiotic 
consumption and costs [1, 3]. 
The possible, positive impact of HAI surveillance on HAI incidence was first described in the 
landmark study on the efficacy of nosocomial infection control (SENIC) [4]. Surveillance may be 
effective through two mechanisms: guidance of infection prevention and control (IPC) programmes 
through feedback of empirical data, or a “surveillance effect”, i.e. the simple fact of being conscious 
of being observed may independently lead to improved practices [5]. 
The role of SSI surveillance was recently highlighted in the World Health Organization’s 
Global guideline to prevent SSI [6], and the core components [7], but its impact has not been 
quantified in these guidelines. Furthermore, there are few reports that consider surveillance data not 
by calendar year, but rather from a “length of participation” perspective (as an exposure); in these, 
data were stratified by years since start of participation of hospitals in the network. In surveillance 
networks, larger teaching hospitals are usually the first to enter, and smaller clinics (with less complex 
case-mix) join later; consequently, SSI rates could be artificially decreased in later years. In a recent 
systematic review, the impact of surveillance was evaluated from a length of participation 
perspective, and there was evidence of a decrease of SSI rates during the first five years of 
participation in a surveillance network [8]. However, as few networks (n=4) have published studies 
presenting surveillance data in this manner, we were unable to perform procedure-specific analyses.  
The objective of this study was to undertake a large-scale international study to determine the 
time-trend of SSI incidence (hereafter referred to as rates) in SSI surveillance networks, using hospital 
data aggregated at the network level, by actively collecting detailed data directly from the 
management teams of a wide selection of networks around the world. 
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Methods 
We conducted an international retrospective cohort study, based on data from as many SSI 
surveillance networks as possible. The networks, defined as entities that collect surveillance data from 
hospitals, were identified through the PubMed® search of the systematic literature review [8], as well 
as a Google® search. For low-income countries in the WHO African region, the leadership of 
Infection Control Africa Network (ICAN) was contacted. There were no exclusion criteria for the 
networks in terms of how surveillance was conducted (including whether prospective, retrospective, 
or a mix of both), although a minimum of three years of surveillance per procedure was required. We 
followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
guidelines in drafting the manuscript [9]. 
The networks were provided with a standardized data collection template, and were requested 
to provide procedure-specific data on the number of operations and SSIs aggregated at the network 
level, stratified by year since individual hospitals’ start of participation in the surveillance network 
according to previously-defined methods [5, 10-13]. Non-consecutive years of surveillance by a 
hospital were ignored, up to a maximum ‘gap’ of four years. Where possible, networks provided data 
additionally stratified by the National Healthcare Safety Network (NHSN) National Nosocomial 
Infection Surveillance (NNIS) risk index [14]. 
To capture certain operational characteristics of the networks, a survey was undertaken, with 
the questionnaire developed jointly with a member of one network (TL), and was pilot-tested before 
being sent to all participating networks. Items on the questionnaire (Supplementary Appendix) 
included questions on network functioning, surveillance and quality control practices, and existence 
of network-level or national quality improvement practices. 
We included all the procedures for which the networks provided data. Procedures for which 
only one network provided data were included in the pooled analysis, but excluded from the 
procedure-specific analysis for purposes of confidentiality; this included gastric surgery, repair of 
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neck of femur, small bowel surgery, and ventricular shunt surgery. We regrouped certain procedures 
with different procedure codes into broader categories; colon surgery, colorectal surgery, and rectal 
surgery were regrouped into “colorectal surgery”, and discectomy, spinal fusion, laminectomy and 
lumbar surgery were regrouped into “spinal surgery”. 
 
Statistical analysis 
The primary analysis consisted of evaluating changes in SSI rates, comparing each additional 
surveillance year to the first surveillance year (year 1, reference). A random-effects Poisson 
regression was applied, including sum of SSIs as a dependent variable, year as a categorical 
independent variable, and the total number of operations as an offset. In addition, network was 
included as random intercept to take into account clustering effects (or intra-network correlation), as 
in the study by Minalu et al [15]. The likelihood ratio test was used to confirm presence of intra-
cluster correlation or whether variation between network intercepts was significant. We calculated 
cumulative annual SSI rates and 95% confidence intervals (CI), followed by yearly rate ratios (RR) 
with 95% CI. Crude pooled and procedure-specific analyses, as well as pooled analyses stratified by 
the NNIS risk index, were performed. To evaluate year-to-year changes, a secondary analysis was 
performed where estimates for each year (y) are provided using the previous year (y -1) as a reference. 
To evaluate whether there was an overall change in SSI rates over the surveillance period, we 
repeated the random-effects Poisson regression using year as a continuous variable. 
We restricted the Poisson analysis to the years included in the 90th percentile of the overall, 
cumulative sum of operations for two reasons. Firstly, there was considerable heterogeneity in the 
duration of surveillance by network and by procedure, so that the number of networks gradually 
declined as well as the number of operations. Secondly, by performing a stratification by years of 
participation we deemed it likely that, because larger and/or teaching hospitals participate longer (i.e. 
join the network earlier in calendar years), they would be over-represented in the later years, 
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compared to smaller hospitals with a different case-mix, which could artificially increase SSI rates; 
the inverse effect of presenting the results by calendar year. 
 
Subgroup and sensitivity analyses 
We performed two subgroup analyses; the first was on the subset of procedure-specific data where 
SSI rates were stratified by the NNIS risk index (minimal number of operations = 100,000); unknown 
categories were ignored. The second was based on responses provided by the networks in the 
questionnaire relating to mandatory post-discharge surveillance, routine quality control, 
benchmarking, and mandatory/voluntary reporting. These analyses were performed using a 
multivariate random-effects Poisson model, and, if indicated by the likelihood ratio test, interaction 
terms between the network characteristic and the year of surveillance were included. The SSI rates 
predicted by the model were then graphed. A sensitivity analysis was performed by including 
published data obtained from the study by American College of Surgeons National Surgical Quality 
Improvement Program (ACS NSQIP) [13]. 
All statistical analyses were performed using Stata version 14 (StataCorp. 2015. College 
Station, TX). A two-tailed p-value of ≤0.05 was considered for statistical significance. 
 
 
Results 
Seventeen networks from 15 countries from three continents (Asia, Australia, and Europe) 
participated in the study: Australia (Queensland, Victoria, and Western Australia), Austria, England, 
Finland, France, Germany, Hungary, The Netherlands, Norway, Scotland, Spain (Catalonia), 
Singapore, South Korea, Switzerland, and Wales. The remaining 19 invited networks either declined 
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(n=2), were unable to provide data stratified by year of participation in the network (n=3), did not 
respond to requests (n=13), or had been conducting surveillance for < 3 years (n=1). 
 
Survey results 
We received completed questionnaires from all 17 participating networks. The median year of 
establishment of the networks was 2003 (interquartile range (IQR) 1999-2005), and the median 
number of participating hospitals increased from 28 (IQR 9-42) in the first year to 43 (IQR 20-124) 
participating at the time of questionnaire completion (February 2017) or end of network activity. Over 
three-quarters (n=13) of the networks had no restrictions as to which hospitals could participate in the 
network, and over half (n=10) of the networks reported a catchment of >80% of hospitals in the 
region/country. Nine networks used CDC definitions (either 2016 update [n=2] or 1999 definition 
[n=7]), and 5 used ECDC definitions. Hospital surveillance and reporting of SSI is voluntary in 6 
networks, mandatory in 5, and a mixture of voluntary and mandatory in 6. Post-discharge surveillance 
(PDS) was performed in 15 networks; mandatory in 10 networks, and recommended (but not 
mandatory) in 5. Feedback to surgical departments or surgeons was encouraged or required by 14 
networks; of these, 11 facilitated the provision of feedback. Quality control of the data submitted by 
the hospitals was routinely performed by 5 of the networks, and occasionally by 7. Five networks 
underwent significant changes to surveillance methodology during the years for which they submitted 
data. The changes included duration of follow-up (n=2) and stepwise changes from intermittent to 
continuous surveillance (n=1). Over two-thirds (n=12) of the networks reported the implementation of 
structured quality improvement initiatives. More detailed findings of the questionnaires are 
summarized in Supplementary Table S1.  
 
Characteristics of included operations 
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 Networks provided data on 23 types of surgical procedures before being regrouped into 17 
(appendectomy, coronary artery bypass graft, cholecystectomy, colon surgery, colorectal surgery, 
craniectomy, Caesarean section, discectomy, femoral neck repair, spinal fusion, gastric surgery, 
herniorrhaphy, hip and knee prosthesis, hysterectomy [abdominal and vaginal], laminectomy, lumbar 
surgery, mastectomy, rectal surgery, small bowel surgery, peripheral vascular bypass surgery, 
ventricular shunt), 5,831,737 operations and 113,166 SSIs, yielding an overall cumulative SSI rate of 
1.94% (95% CI 1.93-1.95). The number of networks and the median number of operations per 
network, and median duration of surveillance for each procedure are shown in Table 1. Overall, the 
median yearly number of operations under surveillance was 12,492 (interquartile range (IQR) 7,787-
24,628), and the median number of years of surveillance was 9 (IQR 7-14) (Table 1). The median 
number of procedures each network contributed data to was 6 (IQR 3-10). Three networks (France, 
England, and Germany) provided 69.6% of all the operations.  
 For each procedure, the number of operations, the number of networks contributing data, and 
the median number of years of surveillance are shown in Table 2. Orthopaedic, digestive, and 
gynaecologic surgery contributed 90.5% of all operations, with 46.1%, 22.8%, and 21.6%, 
respectively. The highest cumulative SSI rate was observed in colorectal surgery (9.33%; 95% CI 
9.23-9.44), and the lowest was observed in spinal surgery (0.62%; 95% CI 0.58-0.66) (Table 2). The 
procedure-specific distribution of operations and SSIs, and SSI rates stratified by NNIS risk index are 
shown in Supplementary Table S2. 
 
Primary (pooled) analysis 
There was significant variation between networks and the likelihood ratio test indicated that random-
effects Poisson regression gave a better fit of the data for both the overall SSI RR and RR stratified by 
the NNIS risk index; therefore, only results from this model are presented. Overall, there was a 
statistically significant gradual decrease in the overall SSI RR from participation years 2 to 9 when 
compared to year 1 (Figure 1A), with RR 0.65 at year 9 (95% CI 0.63-0.67) (Table 3A). For SSI rates 
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stratified by NNIS risk index there was also a significant gradual decrease of SSI RR (Figure 1B-D). 
The SSI RR in the final year compared to year 1 for NNIS-0 to NNIS-3 procedures, respectively, 
were 0.59 (95% CI 0.56-0.63), 0.73 (95% CI 0.69-0.78), 0.67 (95% CI 0.60-0.73), 0.51 (95% CI 0.38-
0.68). When yearly SSI RR were compared using the preceding year as reference, statistically 
significant year-to-year decreases were observed for most years of surveillance for overall and NNIS-
0 SSI RR (Table 3B); the greatest decreases were observed on the second and seventh year of 
surveillance. For NNIS-1 and NNIS-2, there were decreases observed for most years of surveillance 
but they were mostly non-significant, except for years 2, 3, and 7, where the decreases were 
significant (Table 3B). For NNIS-3, the only observed significant change was a decrease at year 9 
(RR 0.59; 95% CI 0.42-0.83). 
 
Procedure-specific analysis 
For all procedure categories, there was significant variation between networks and the likelihood ratio 
test indicated that random-effects Poisson regression gave a better fit to the overall (i.e. not NNIS-
stratified) data; therefore, only results from this model are presented. The graphs of the yearly SSI RR 
for each procedure category are shown in Figure 2 and the corresponding numbers in Supplementary 
Table S3. The impact is not uniform across all procedure categories. 
The yearly RRs, calculated using year 1 as reference, were all significantly decreased for 
colorectal surgery, herniorrhaphy, Caesarean section, hip prosthesis, and knee prosthesis. For these 
procedures, when yearly SSI RR were calculated using each preceding year as reference, there was a 
significant decrease in year 2. For the remaining years, there were few statistically significant year-to-
year decreases, apart from Caesarean section, where there were consistent decreases up to year 7. 
For cardiac surgery, coronary artery bypass surgery, peripheral vascular bypass surgery, 
appendectomy, cholecystectomy, abdominal hysterectomy, mastectomy, and spinal surgery, there 
were significant decreases in SSI RR for some, but not all years. For vaginal hysterectomy, and 
craniectomy, there were no significant changes in SSI RR in any year, either when using year 1 or 
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each preceding year as reference. For craniectomy, there were statistically significant increases in SSI 
RR for years 3 and 4. 
 
Subgroup analyses 
For SSI RR stratified by the NNIS risk index, the random-effects Poisson regression also performed 
better for most procedures for NNIS-0 to NNIS-2 (Supplementary Table S4). For NNIS-3, due to the 
small sample size and number of SSI, the model only performed well for appendectomy, 
cholecystectomy, and colorectal surgery. In general, there were non-significant changes for most 
procedures in each NNIS risk index category. For NNIS-0, there were significant decreases observed 
in most years for cholecystectomy, herniorrhaphy, hip prosthesis, knee prosthesis, and spinal surgery. 
For NNIS-1, there were significant decreases observed in most years for appendectomy, 
herniorrhaphy, hip prosthesis, and knee prosthesis. For NNIS-2, there were significant decreases 
observed in most years for colorectal surgery, herniorrhaphy, and hip prosthesis. 
When comparing networks with and without certain characteristics, such as routine quality 
control, mandatory PDS, mandatory reporting, provision of feedback, and benchmarking, there were 
no statistically significant differences in baseline SSI rates between networks with and those without 
the characteristic. Overall, there were no significant differences between the yearly rates, except for 
benchmarking in year 7 and 8 (Supplementary Figure 1). 
 
Sensitivity analysis 
When including the data from ACS-NSQIP for the overall trend analysis, the effect persisted, albeit 
with slightly lower RR (Supplementary Table S5). The nadir RR was observed at year 8 (RR 0.83; 
95% CI 0.81-0.84) when including ACS-NSQIP data, and at year 9 (RR 0.65; 95% CI 0.63-0.67) 
when excluding these data. 
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Discussion 
In this large, international cohort study, we included data on more than 5 million operations derived 
from 17 SSI surveillance networks from three continents over an average of 9 years. Our results show 
a strong and sustainable decrease in SSI rates subsequent to hospitals joining surveillance networks, 
particularly after two years of participation. This provides support for the impact of surveillance as a 
means to reduce infection rates.  
When we repeated the analysis stratified for NNIS risk category, we found that overall, and 
for the subset of procedures with a large volume of operations, such as hip prosthesis and knee 
prosthesis, the surveillance effect was confirmed. Unfortunately, for many procedures, the sample size 
was too small to conduct analyses stratified by NNIS risk index; also, the NNIS risk index analysis 
was only based on the subset of data available. 
The mechanisms by which this decrease occurred may either be through feedback and/or the 
surveillance effect. Indeed, most of the networks reported the implementation of structured quality 
improvement initiatives in the field of SSI prevention on a national/regional level during the 
surveillance period.  This is consistent with one of the aims of surveillance, which is to guide and 
evaluate IPC interventions, and both should act in concert [7]. Surveillance and feedback give the 
participating institutions an opportunity to compare their results with and learn from their peers; they 
could also be used by participants to “persuade” their hospital administration to provide more support 
for SSI reduction measures. Therefore, specific SSI measures may occur as a result of surveillance 
data. In effect, active surveillance entails the cycle of data collection, feedback to relevant stake-
holders, implementation of an intervention, and evaluation of the intervention. These measures could, 
for example, include improved pre-operative antibiotic prophylaxis, or decolonization of 
Staphylococcus aureus carriers. One may argue that a reduction in SSI rates could also be related to 
reduced case-finding over time (so-called “fatigue effect”), but it has already been demonstrated that 
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with increasing experience, the accuracy of surveillance by infection control practitioners is rather 
improved, both in terms of sensitivity and specificity [16]. 
The results of this study are aligned with what previous single-network studies have shown 
when analysing surveillance data from a “length of surveillance” perspective (up to 46% reduction in 
SSI in knee prosthesis) [5, 8, 12, 13, 17, 18], as well as reported in a recent systematic literature 
review (up to 20% decrease) [8]. These findings support the pivotal role surveillance can play in IPC, 
and underpin the importance of implementation of surveillance and, possibly, regional benchmarking. 
What remains to be determined is the cost-effectiveness of active surveillance for SSI prevention. 
Indeed, active clinical surveillance at the bedside requires substantial resources which are not 
available in all facilities in many countries, especially in low or middle income areas. 
The fact that not all procedure categories have shown decreased SSI rates with time, and some 
have even shown increases, has already been reported [10]. This may be evidence of the fact that the 
incremental benefit of surveillance and interventions may be greater in some areas than others. This 
may help to guide the development of interventions, as rate reduction in some procedures may be the 
“low hanging fruit”. 
This study has several limitations. First, as mentioned, it is impossible to disentangle the 
“surveillance effect” from the effect of implementing specific prevention interventions, or quality 
improvement initiatives recommended in guidelines [19-21], either in response to, or unrelated to 
reported SSI rates. However, to assess whether this decrease was solely caused by specific 
interventions would entail analysing each individual hospital’s experience and timing of interventions. 
Unfortunately, this could not be formally tested due to lack of individual hospital-level data, which 
also precluded us from evaluating the effect of changes in the surveillance methodology of five 
networks. 
Second, by stratifying hospital data by year of surveillance, there is a possibility of an inverse 
phenomenon to what occurs when data are presented by calendar year; because smaller 
hospitals/clinics or private institutes participate for fewer years, they may be increasingly 
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underrepresented with each subsequent year, leading to changes in case-mix and possible artificial 
increases in SSI rates. Residual confounding may still occur due to hospitals joining surveillance for 
the first time at a later time point but by then exposed to a stronger culture of IPC practices due for 
example to intensified national efforts [22]. Although, these late joiners may contribute lower SSI risk 
to the group designated as first or two years of participation, the random effects component of the 
model would take into account unobserved heterogeneity not related to surveillance effect. To further 
mitigate this risk, we restricted the Poisson analysis to the 90th percentile of the overall, cumulative 
sum of operations per year, and in these analyses, we did not observe a negative change in risk 
reduction over the years. This 10% tail is likely to include mostly larger hospitals and tertiary referral 
centres with higher levels of case mix and surgeons doing higher volume of surgery. Higher volumes 
and frequent exposure to complex surgery may be associated with lower adverse outcomes [23]. 
Third, we acknowledge that networks operate differently, for example regarding the definition 
of SSI or procedure, the collection of post-discharge surveillance data, implementation of mandatory 
surveillance with publicly reportable figures, intensity of national policies to reduce HAI or the 
background characteristics of patients under surveillance [24]. Although this precludes inter-network 
comparisons, we do not believe this hinders our analysis, as each network acts as its own control, and 
random effects Poisson analysis took intra-cluster correlation into account.  
Finally, the external validity of the presented results is limited for two reasons. We obtained 
no data from low- and middle-income countries, either because surveillance networks collecting 
incidence-based data do not exist, or because they were unable to provide these data. Also, we have 
not collected data from hospitals that perform surveillance outside of networks; however, there is no 
reason to assume that the observed effect would be different. 
To the best of our knowledge, this is the first study making use of the strength of numbers, by 
looking at trends in SSI rates among multiple surveillance networks. In addition, we eliminated 
confounding by hospital-mix over surveillance years by stratifying SSI rates per year since start of 
participation, instead of calendar year. Finally, we applied random-effects models to take into account 
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intra-network baseline SSI rates. Our study’s findings are important as they provide insight as to 
optimal timing of evaluation of the impact of quality improvement, notably that it should not be 
performed earlier than 2 years. Also, it provides contemporary data with which other networks can 
benchmark. 
 In conclusion, this study demonstrates that SSI surveillance is associated with decreased SSI 
rates, across major procedure categories, and across multiple networks. This warrants investment in 
SSI surveillance activities for those healthcare facilities not yet participating in any SSI surveillance 
network, although cost-benefit ratios and the impact in low, and middle-income countries remains to 
be determined.  
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Figure legends 
Figure 1. Yearly pooled surgical site infection (SSI) rate ratios (RR) for all (A) and risk-stratified 
procedures NNIS-0 (B), NNIS-1 (C), NNIS-2 (D), and NNIS-3 (E), with hospitals’ first year of 
participation in surveillance as reference, 95% CI based on random effects Poisson regression models. 
 
Figure 2. Yearly procedure-specific surgical site infection (SSI) crude rate ratios (RR) with year 1 as 
reference, 95% CI based on random effects Poisson regression models. 
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